Duplicative Federal Retiree Drug Coverage Costing Taxpayers and Federal Retiree Millions

Chairman Waxman and Subcommittee Chairman Davis wrote to CMS and OPM asking why over 200,000 retirees with federal retiree drug coverage have also enrolled for duplicative and unnecessary Medicare Part D drug benefits, and why CMS and OPM have not coordinated these benefits, wasting as much as $200 million in retiree and taxpayer funds annually.